Skip to content
Back to Guavy Wire
Stocks

Mectizan Donation Program Hits 5 Billion Doses Milestone

Instruments
MRK
Share

The Mectizan Donation Program (MDP) has reached a significant milestone - its 5 billionth dose of medication. Established in 1987, the program is the longest-running drug donation initiative for neglected tropical diseases.

Working with partners in 58 countries across Africa, Latin America, the Caribbean, the Middle East, Southeast Asia, and the Western Pacific, MDP aims to eradicate river blindness (onchocerciasis) and lymphatic filariasis (LF or elephantiasis). These debilitating illnesses affect millions of people worldwide.

The program relies on national efforts, where local organizations work with community-directed distributors to ensure everyone in endemic areas has access to treatment. Merck & Co., Inc.* donates Mectizan® to eligible countries where these diseases are prevalent.

More on Stocks

Disclaimer: Guavy is a data and market intelligence provider, not an investment adviser. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

© 2026 Guavy Inc